Psychiatry and Neurology, Neurology · Medina, OH
NPI
1891808135
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
4001 Carrick Dr Ste 170
Medina, OH, 44256
Phone (330) 721-8594
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
17,512 services
Medicare patients, 2024
113
Average age 66
Drug cost, 2024
$1.3M
3,559 prescriptions
Company payments, 2025
$22K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deborah A Reed was code J0585 (injection, onabotulinumtoxina, 1 unit), 16,825 times for 30 patients. In total Deborah A Reed billed 17,512 services in 24 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 16,825 | 30 | $4.84 | $81K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 180 | 15 | $0.50 | $89.22 |
| 64615 Musculoskeletal | Office | 95 | 33 | $106.41 | $10K |
| 96372 Injection Administration | Office | 72 | 21 | $10.28 | $740 |
| 99215 Office E&M - Established | Office | 50 | 40 | $121.70 | $6,085 |
| 99214 Office E&M - Established | Office | 40 | 35 | $86.17 | $3,447 |
| 99213 Office E&M - Established | Office | 37 | 30 | $57.53 | $2,129 |
By year: 2022 $125K for 20,724 services; 2023 $126K for 20,374 services; 2024 $110K for 17,512 services.
Medicare prescription drug claims, 2024
In 2024, the drug Deborah A Reed prescribed most often to Medicare patients was Sumatriptan Succinate, with 247 prescriptions and refills. In total Deborah A Reed wrote 3,559 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sumatriptan Succinate Generic | 247 | 286 | 49 | $17K |
| Nurtec Odt Rimegepant Sulfate | 161 | 161 | 34 | $246K |
| Ubrelvy Ubrogepant | 158 | 160 | 24 | $236K |
| Aimovig Autoinjector Erenumab-Aooe | 154 | 172 | 20 | $128K |
| Gabapentin Generic | 147 | 216 | 32 | $2,703 |
| Tizanidine Hcl Generic | 138 | 212 | 30 | $1,654 |
| Emgality Pen Galcanezumab-Gnlm | 136 | 156 | 21 | $109K |
| Cyclobenzaprine Hcl Generic | 95 | 129 | 20 | $877 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 86 | 86 | 11 | $1,654 |
| Topiramate Generic | 85 | 196 | 29 | $967 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 80 | 81 | 15 | $3,235 |
| Rizatriptan Rizatriptan Benzoate | 76 | 110 | 21 | $1,824 |
| Emgality Syringe Galcanezumab-Gnlm | 71 | 81 | Under 11 | $139K |
| Ondansetron Hcl Generic | 70 | 70 | 23 | $1,011 |
| Naratriptan Hcl Generic | 67 | 69 | 16 | $2,541 |
Brand drugs: 972 claims; generic drugs: 2,587 claims; opioid claims: 302.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deborah A Reed $22K ($22K in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $13K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.